Immuneering (IMRX) had the highest return between February 17, 2023 and April 30, 2023 by a small-cap US stock, returning 158.4%.
| ASSET | DATE | % RETURN |
|---|---|---|
Immuneering (IMRX) | 2/17/2023 - 4/30/2023 | 158.35% |
American Coastal Insurance (ACIC) | 2/17/2023 - 4/30/2023 | 147.3% |
Pulse Biosciences (PLSE) | 2/17/2023 - 4/30/2023 | 122.84% |
Collective Mining (CNL) | 2/17/2023 - 4/30/2023 | 105.36% |
Sophia Genetics (SOPH) | 2/17/2023 - 4/30/2023 | 89.8% |
Eyepoint Pharmaceuticals (EYPT) | 2/17/2023 - 4/30/2023 | 75.42% |
Neurogene (NGNE) | 2/17/2023 - 4/30/2023 | 75.39% |
Xeris Pharmaceuticals (XERS) | 2/17/2023 - 4/30/2023 | 75.19% |
Hyster-Yale Materials Handling (HY) | 2/17/2023 - 4/30/2023 | 74.04% |
ThredUp (TDUP) | 2/17/2023 - 4/30/2023 | 72.55% |
Mercurity Fintech Holding Inc ADR (MFH) | 2/17/2023 - 4/30/2023 | 66.88% |
Aquestive Therapeutics (AQST) | 2/17/2023 - 4/30/2023 | 65.6% |
Opera (OPRA) | 2/17/2023 - 4/30/2023 | 63.61% |
Burford Capital (BUR) | 2/17/2023 - 4/30/2023 | 62.04% |
Crawford (CRD.A) | 2/17/2023 - 4/30/2023 | 51.28% |
Betterware de México, SAPI de CV (BWMX) | 2/17/2023 - 4/30/2023 | 50.05% |
X4 Pharmaceuticals (XFOR) | 2/17/2023 - 4/30/2023 | 50% |
Amprius Technologies (AMPX) | 2/17/2023 - 4/30/2023 | 49.36% |
Ardelyx (ARDX) | 2/17/2023 - 4/30/2023 | 48.67% |
Arlo Technologies (ARLO) | 2/17/2023 - 4/30/2023 | 48.05% |
Heritage Insurance Hldgs (HRTG) | 2/17/2023 - 4/30/2023 | 47.58% |
Mistras (MG) | 2/17/2023 - 4/30/2023 | 46.04% |
Crawford (CRD.B) | 2/17/2023 - 4/30/2023 | 45.28% |
Beazer Homes USA (BZH) | 2/17/2023 - 4/30/2023 | 44.77% |
Corvus Pharmaceuticals (CRVS) | 2/17/2023 - 4/30/2023 | 44% |
Small-cap stocks are treated as having a market cap between $300M and $2B.
